William Harris Investors’s Ironwood Pharmaceuticals IRWD Stock Holding History

William Harris Investors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$301K	Hold	23,476	–	–	0.09%	78
2016 Q3	$312K	Hold	23,476	–	–	0.08%	70
2016 Q2	$257K	Hold	23,476	–	–	0.06%	81
2016 Q1	$215K	Hold	23,476	–	–	0.05%	84
2015 Q4	$228K	Hold	23,476	–	–	0.05%	79
2015 Q3	$205K	Hold	23,476	–	–	0.06%	83
2015 Q2	$237K	Hold	23,476	–	–	0.07%	81
2015 Q1	$315K	Hold	23,476	–	–	0.08%	69
2014 Q4	$301K	Hold	23,476	–	–	0.08%	68
2014 Q3	$255K	Hold	23,476	–	–	0.08%	70
2014 Q2	$301K	Hold	23,476	–	–	0.08%	72
2014 Q1	$242K	Hold	23,476	–	–	0.07%	77
2013 Q4	$228K	Hold	23,476	–	–	0.07%	80
2013 Q3	$233K	Hold	23,476	–	–	0.07%	80
2013 Q2	$195K	Buy	+23,476	New	+$285K	0.06%	85

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Harris Investors's IRWD Position: Q4 2016 in Review

William Harris Investors held its Ironwood Pharmaceuticals (IRWD) position steady in Q4 2016 at 23,476 shares worth $301K. The position accounts for 0.09% of the portfolio, ranked #78.

William Harris Investors first reported a position in IRWD in Q2 2013 and has held it in 15 quarters since. The position peaked at $315K in Q1 2015. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

William Harris Investors held 23,476 shares of Ironwood Pharmaceuticals worth $301K as of Q4 2016.
William Harris Investors left its Ironwood Pharmaceuticals share count unchanged in Q4 2016.
Ironwood Pharmaceuticals made up 0.09% of William Harris Investors's portfolio in Q4 2016, its #78 holding.
William Harris Investors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
William Harris Investors's Ironwood Pharmaceuticals position peaked at $315K in Q1 2015.
163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.